ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $97,424, the best ever quarter in terms of revenues in corporate history and an increase of more than 25% over the $77,776 recorded in the third quarter, fiscal year 2008. Net income after taxes in Q3FY09 was $6,439 resulting in fully diluted earnings per share (EPS) of $.46, up 36% each from the prior fiscal year third quarter net income after taxes of $4,737 and EPS of $.34. Gross profit on revenues for the current quarter was $49,261 resulting in a margin for gross profit on revenues of 51%, versus the $38,606, or 50%, reported for the prior fiscal year third quarter. Revenue per patient for the third quarter of the current fiscal year was $77.61, an increase of 5% over the $74.11 reported for the same quarter of the prior fiscal year. The number of patients served increased 20% to 1,246 in the current quarter from the prior year third quarter total of 1,042. Esoteric business for the Company was 53% of revenues for the third quarter of the current fiscal year. Cash flow from operations for the current fiscal year quarter was more than $11 million. The Company further noted that Days Sales Outstanding (DSO) were 95 days compared to the prior fiscal year same period when the DSO were 108 days.
